Remove topics tax-preparers
article thumbnail

Strategic Moves: Navigating Mergers & Acquisitions Seminar

LexBlog IP

We invite you to join members of Henderson Franklin’s Business & Tax team on Tuesday, November 7, 2023, for an event aimed to equip attendees with valuable knowledge when contemplating strategic moves in this corporate arena. She’s a principal and chair of the Tax Advisory Group at HBK CPAs & Consultants.

article thumbnail

What’s in an Italian Patent (Innovation) Box? Patents, software and design (but no more know-how, ouch!)

The IPKat

As many of our readers know one of the most recurrent tax-related topics that come into discussion in the IP field is the so-called Patent Box (sometimes also - more properly - defined as the Innovation Box since it is not all about patents ). 50 of 24.4.2017).

Designs 70
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SpicyIP Weekly Review (January 02- January 09)

SpicyIP

ITAT clarifies that deductions for clinical trials conducted by outsourced agencies can be claimed under Section 35 (2AM) of the Income Tax Act. Micro Labs Limited vs The Assistant Commissioner Of Income Tax on 4 January, 2023 (Income Tax Appellate Tribunal).

Trademark 105
article thumbnail

AIPPI Congress (Report 1): Is IP the "bogeyman" in access to Covid-19 vaccines?

The IPKat

This is the first in-person Congress since London hosted in 2019, so it was only apt that the first panel session was on the topic of IP and Covid-19. many countries prepared their legislation for compulsory licenses). Wolf returned to the IP incentivization topic, but noted there was also the important “access” to vaccine issue.

article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., Sandoz Inc. Immunex Corp. , 2623 (Mem) (2021).